PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1994 | 16 |
| 1995 | 101 |
| 1996 | 101 |
| 1997 | 129 |
| 1998 | 119 |
| 1999 | 119 |
| 2000 | 78 |
| 2001 | 89 |
| 2002 | 91 |
| 2003 | 29 |
| 2004 | 16 |
| 2005 | 8 |
| 2006 | 46 |
| 2007 | 71 |
| 2008 | 97 |
| 2009 | 55 |
| 2010 | 85 |
| 2011 | 119 |
| 2012 | 151 |
| 2013 | 61 |
| 2014 | 63 |
| 2015 | 127 |
| 2016 | 92 |
| 2017 | 28 |
| 2018 | 66 |
| 2019 | 63 |
| 2020 | 126 |
| 2021 | 162 |
| 2022 | 165 |
| 2023 | 171 |
| 2024 | 284 |
| 2025 | 362 |
| 2026 | 182 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Mol Med"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Global estimates of infertility burden and contributions of congenital, endocrine, metabolic and infectious factors.
- Wang J, Gan C, Jia Z, Zheng Z, Zhang Y, Liang H.
- Mol Med. 2026 Jul 28;32(1):192. doi: 10.1186/s10020-026-01548-8.
- PMCID: PMC13692988
Wang J, et al.Mol Med. 2026.PMCID: PMC13692988 -
Cadmium exposure triggers a functional switch of APP to drive joint degeneration.
- Fan Y, Shi M, Zou S, Lu Z, Gou X, Zhu J, Feng S.
- Mol Med. 2026 Aug 14;32(1):191. doi: 10.1186/s10020-026-01603-4.
- PMCID: PMC13688780
Fan Y, et al.Mol Med. 2026.PMCID: PMC13688780 -
Drugs inducing interstitial lung disease: in silico analysis of their structures and targets.
- Tanabe M, Takahama S, Yamamoto T, Sakate R.
- Mol Med. 2026 Jul 21;32(1):190. doi: 10.1186/s10020-026-01559-5.
- PMCID: PMC13678984
Tanabe M, et al.Mol Med. 2026.PMCID: PMC13678984 -
Integrated analysis of STRC variants in hereditary hearing impairment using maker-mediated refinement of long-read sequencing with MLPA validation.
- Tsai CY, Lu YS, Chiang YT, Lo MY, Lin PH, Tsai SF, Hsu CJ, Chen PL, Hsu JS, Wu CC.
- Mol Med. 2026 Jul 13;32(1):189. doi: 10.1186/s10020-026-01553-x.
- PMCID: PMC13679130
Tsai CY, et al.Mol Med. 2026.PMCID: PMC13679130 -
O-GlcNAcylation: the metabolic-immune translator in tumor evolution and treatment.
- Zhao J, Lv J, Wang H, Zheng Z, Xin Y, Jiang X.
- Mol Med. 2026 Jul 20;32(1):188. doi: 10.1186/s10020-026-01573-7.
- PMCID: PMC13673830
Zhao J, et al.Mol Med. 2026.PMCID: PMC13673830 -
OGT as a metabolic-epigenetic integrator in cancer: context-dependent mechanisms and therapeutic vulnerabilities.
- El Hajje M, Trossini GHG.
- Mol Med. 2026 Jul 18;32(1):187. doi: 10.1186/s10020-026-01563-9.
- PMCID: PMC13670683
El Hajje M, et al.Mol Med. 2026.PMCID: PMC13670683 -
Elucidating the mechanism underlying incomplete immune recovery in people living with HIV through CD4⁺ and CD8⁺ T cell multi-omics.
- Flores-Piñas M, Chafino S, Viladés C, Domingo P, Villar B, Prieto P, Inciarte A, Mallolas J, Blanco J, Negredo E, Navarro J, Elizalde-Horcada M, Alba V, Martí A, Pacheco YM, Vidal F, Peraire J, Rull A.
- Mol Med. 2026 Aug 7;32(1):186. doi: 10.1186/s10020-026-01575-5.
- PMCID: PMC13663302
Flores-Piñas M, et al.Mol Med. 2026.PMCID: PMC13663302 -
A TRIM15-CDX2 loop drives bile acid-induced gastric intestinal metaplasia.
- Wang D, Chen J, Xu W, Shrestha SM, Lu Q, Ren L, Ji Q, Wu H, Shi R.
- Mol Med. 2026 Aug 6;32(1):185. doi: 10.1186/s10020-026-01578-2.
- PMCID: PMC13663074
Wang D, et al.Mol Med. 2026.PMCID: PMC13663074 -
Secretory leukocyte protease inhibitor (SLPI) attenuates TLR4/NF-κB-mediated neuroinflammation in amyotrophic lateral sclerosis: a candidate molecule associated with neuro-pathology.
- Li MA, Song YZ, Li T, Wu J, Tao Y, Hu R, Qiao CM, Cui C, Zhao WJ, Shen YQ.
- Mol Med. 2026 Jul 17;32(1):184. doi: 10.1186/s10020-026-01572-8.
- PMCID: PMC13660176
Li MA, et al.Mol Med. 2026.PMCID: PMC13660176 -
A multiomic investigation of human milk-derived extracellular vesicles in perinatal HIV and antiretroviral therapy exposure.
- Kupsco A, Jao J, Myer L, Abrams EJ, Wang F, Dominguez J, Zerbe A, Mukonda E, Madlala HP, Matyesini S, Robinson DT, Qiu Y, Kurland IJ, Wu H.
- Mol Med. 2026 Jul 16;32(1):183. doi: 10.1186/s10020-026-01567-5.
- PMCID: PMC13656393
Kupsco A, et al.Mol Med. 2026.PMCID: PMC13656393